The total return over the past 12 months is -25.72% vs. +16.94% for the S&P 500. So far it's up +23.99% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (25.72%) | (12.98%) | (39.98%) | N/A | N/A | N/A |
| Total Return CAGR | (25.72%) | (12.98%) | (39.98%) | N/A | N/A | N/A |
| Revenue CAGR | (1.83%) | +1.76% | +4.47% | N/A | N/A | N/A |
| Net Income CAGR | (62.12%) | +11.28% | N/A | N/A | N/A | N/A |
| EPS CAGR | (55.54%) | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | +9.29% | +28.02% | +11.72% | N/A | N/A | N/A |
| Operating Cash Flow CAGR | +5.76% | +16.41% | +9.52% | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
GoodRx Holdings, Inc. (GDRX)
| Year | Start price | End price | GDRX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $2.71 | $3.36 | +23.99% | +14.51% | +9.48% |
| 2025 | $4.65 | $2.71 | (41.72%) | +17.72% | (59.44%) |
| 2024 | $6.70 | $4.65 | (30.60%) | +24.89% | (55.49%) |
| 2023 | $4.66 | $6.70 | +43.78% | +26.19% | +17.59% |
| 2022 | $32.68 | $4.66 | (85.74%) | (18.17%) | (67.57%) |
| 2021 | $40.34 | $32.68 | (18.99%) | +28.74% | (47.73%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
